Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

被引：0
|
作者：
Goki Suda
Mineo Kudo
Atsushi Nagasaka
Ken Furuya
Yoshiya Yamamoto
Tomoe Kobayashi
Keisuke Shinada
Miki Tateyama
Jun Konno
Yoko Tsukuda
Kazushi Yamasaki
Megumi Kimura
Machiko Umemura
Takaaki Izumi
Seiji Tsunematsu
Fumiyuki Sato
Katsumi Terashita
Masato Nakai
Hiromasa Horimoto
Takuya Sho
Mitsuteru Natsuizaka
Kenichi Morikawa
Koji Ogawa
Naoya Sakamoto
机构：
[1] Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Hokkaido University,undefined
[3] Sapporo Hokuyu Hospital,undefined
[4] Sapporo City General Hospital,undefined
[5] JCHO Hokkaido Hospital,undefined
[6] Hakodate City Hospital,undefined
[7] Tomakomai City Hospital,undefined
[8] Keiwakai Ebetsu Hospital,undefined
[9] Tomakomai Nissho Hospital,undefined
[10] Hakodate Central General Hospital,undefined
来源：
Journal of Gastroenterology | 2016年 / 51卷
关键词：
HCV; Hemodialysis; Daclatasvir; Asunaprevir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 740
页数：7
相关论文
共 50 条
  • [1] Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
    Suda, Goki
    Kudo, Mineo
    Nagasaka, Atsushi
    Furuya, Ken
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Shinada, Keisuke
    Tateyama, Miki
    Konno, Jun
    Tsukuda, Yoko
    Yamasaki, Kazushi
    Kimura, Megumi
    Umemura, Machiko
    Izumi, Takaaki
    Tsunematsu, Seiji
    Sato, Fumiyuki
    Terashita, Katsumi
    Nakai, Masato
    Horimoto, Hiromasa
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (07) : 733 - 740
  • [2] Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
    Reona Morio
    Michio Imamura
    Yoshiiku Kawakami
    Kei Morio
    Tomoki Kobayashi
    Satoe Yokoyama
    Yuki Kimura
    Yuko Nagaoki
    Tomokazu Kawaoka
    Masataka Tsuge
    Akira Hiramatsu
    C. Nelson Hayes
    Hiroshi Aikata
    Shoichi Takahashi
    Daiki Miki
    Hidenori Ochi
    Nami Mori
    Shintaro Takaki
    Keiji Tsuji
    Kazuaki Chayama
    Journal of Gastroenterology, 2017, 52 : 504 - 511
  • [3] Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
    Morio, Reona
    Imamura, Michio
    Kawakami, Yoshiiku
    Morio, Kei
    Kobayashi, Tomoki
    Yokoyama, Satoe
    Kimura, Yuki
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Hayes, C. Nelson
    Aikata, Hiroshi
    Takahashi, Shoichi
    Miki, Daiki
    Ochi, Hidenori
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (04) : 504 - 511
  • [4] Efficacy and Safety of Daclatasvir Plus Asunaprevir Therapy for Chronic Hepatitis C Patients With Renal Dysfunction
    Nakamura, Yuki
    Imamura, Michio
    Kawakami, Yoshiiku
    Teraoka, Yuji
    Daijo, Kana
    Honda, Fumi
    Morio, Kei
    Kobayashi, Tomoki
    Nakahara, Takashi
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Aikata, Hiroshi
    Hayes, C. Nelson
    Miki, Daiki
    Ochi, Hidenori
    Chayama, Kazuaki
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (04) : 665 - 671
  • [5] Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease
    Norihiko Morisawa
    Yohei Koshima
    Jun-ichi Satoh
    Yukio Maruyama
    Satoru Kuriyama
    Takashi Yokoo
    Morimasa Amemiya
    Clinical and Experimental Nephrology, 2017, 21 : 818 - 824
  • [6] Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease
    Morisawa, Norihiko
    Koshima, Yohei
    Satoh, Jun-ichi
    Maruyama, Yukio
    Kuriyama, Satoru
    Yokoo, Takashi
    Amemiya, Morimasa
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 818 - 824
  • [7] Efficacy and tolerability of IFN-free direct acting antivirals therapy (daclatasvir and asunaprevir) in chronic hemodialysis patients with chronic hepatitis C
    Suda, Goki
    Ogawa, Koji
    Morikawa, Kenichi
    Nakai, Masato
    Sakamoto, Naoya
    HEPATOLOGY, 2016, 64 : 975A - 975A
  • [8] Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b-Infected Patients on Hemodialysis
    Miyazaki, Ryoichi
    Miyagi, Kyoko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (05) : 462 - 467
  • [9] Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis
    Hidenori Toyoda
    Takashi Kumada
    Toshifumi Tada
    Koichi Takaguchi
    Toru Ishikawa
    Kunihiko Tsuji
    Mikio Zeniya
    Etsuko Iio
    Yasuhito Tanaka
    Journal of Gastroenterology, 2016, 51 : 741 - 747
  • [10] Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study
    Kawakami, Y.
    Imamura, M.
    Ikeda, H.
    Suzuki, M.
    Arataki, K.
    Moriishi, M.
    Mori, N.
    Kokoroishi, K.
    Katamura, Y.
    Ezaki, T.
    Ueno, T.
    Ide, K.
    Masaki, T.
    Ohdan, H.
    Chayama, K.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (11) : 850 - 856
12345